Table 1.
Laboratory data observed on admission in this subject.
| Variable | Result | Reference range |
| Peripheral blood | ||
| White blood cells (/μL) | 4230 | 3300–8600 |
| Red blood cells (×104/μL) | 397 | 386–492 |
| Hemoglobin (g/dL) | 9.8 | 11.6–14.8 |
| Platelets (×104/μL) | 14.4 | 15.8–34.8 |
| Blood biochemistry | ||
| Total protein (g/dL) | 5.0 | 6.6–8.1 |
| Albumin (g/dL) | 2.9 | 4.1–5.1 |
| Globulin (g/dL) | 2.1 | 2.2–3.4 |
| Total bilirubin (mg/dL) | 0.6 | 0.4–1.5 |
| AST (U/L) | 109 | 7–23 |
| ALT (U/L) | 178 | 13–30 |
| LDH (U/L) | 166 | 124–222 |
| ALP (U/L) | 115 | 106–322 |
| γ-GTP (U/L) | 33 | 9–32 |
| BUN (mg/dL) | 7 | 8–20 |
| Creatinine (mg/dL) | 0.46 | 0.46–0.79 |
| Cholinesterase (U/L) | 201 | 201–421 |
| Uric acid (mg/dL) | 3.9 | 2.6–5.5 |
| Creatine Kinase (U/L) | 17 | 41–153 |
| Amylase (U/L) | 42 | 44–132 |
| CRP (mg/dL) | 0.13 | <0.14 |
| BNP (pg/mL) | 565.9 | 0.0–18.4 |
| Plasma glucose (mg/dL) | 92 | |
| Total cholesterol (mg/dL) | 100 | 142–248 |
| Iron (μg/dL) | 17 | 40–188 |
| Ferritin (ng/mL) | 7 | 5–160 |
| Thyroid marker | ||
| TSH (μU/mL) | <0.010 | 0.400–6.000 |
| FT3 (pg/mL) | 8.14 | 2.50–4.20 |
| FT4 (ng/dL) | 2.02 | 0.80–1.60 |
| Electrolytes | ||
| Sodium (mmol/L) | 142 | 138–145 |
| Potassium (mmol/L) | 3.4 | 3.6–4.8 |
| Chloride (mmol/L) | 108 | 101–108 |
| IP (mg/dL) | 4.7 | 2.7–4.6 |
| Calcium (mg/dL) | 8.1 | 8.8–10.1 |
| Magnesium (mg/dL) | 1.9 | 1.9–2.6 |
| Coagulation fibrinolytic system marker | ||
| PT-sec (s) | 12.2 | 9.3–12.5 |
| PT-INR | 1.09 | 0.85–1.13 |
| PT-activity (%) | 86.4 | 80.7–125.2 |
| APTT (s) | 31.0 | 26.9–38.1 |
| Fibrinogen (mg/dL) | 189 | 160–380 |
| D-dimer (μg/mL) | 5.2 | <1.0 |
| Virus antibody | ||
| HBs antigen | (−) | (−) |
| HCV Ab | (−) | (−) |
| HA-IgM Ab | (−) | (−) |
| CMV IgG Ab | 12.1 (+) | <2.0 |
| CMV IgM Ab | 0.31 (−) | <0.80 |
| EBV anti-VCA IgG Ab | 11.3 (+) | <0.5 |
| EBV anti-VCA IgM Ab | 0.0 (−) | <0.5 |
| EBV anti-EBNA IgG Ab | 3.8 (+) | <0.5 |
| Chlamydia trachomatis IgA | 0.18 (−) | <0.90 |
| Chlamydia trachomatis IgG | 0.12 (−) | <0.90 |
| Thyroid antibody | ||
| TSAb (%) | 1078 | <120 |
| TRAb (U/L) | 8.7 | <1.0 |
| TPOAb (U/mL) | <9.0 | <16.0 |
| TgAb (U/mL) | 18.4 | <28.0 |
γ-GTP = γ-glutamyltranspeptidase, Ab = antibody, ALP = alkaline phosphatase, APTT = activated partial thromboplastin time, AST = aspartate aminotransferase, ALT = alanine aminotransferase, BUN = blood urea nitrogen, BNP = brain natriuretic peptide, CRP = C-reactive protein, EBNA = EBV nuclear antigen, EBV = Epstein-Barr virus, FT3 = free triiodothyronine, FT4 = free thyroxine, HBs = hepatitis B surface, HCV = hepatitis C virus, IgA = immunoglobulin A, IgG = immunoglobulin G, IgM = immunoglobulin M, IP = inorganic phosphorus, LDH = lactate dehydrogenase, PT = prothrombin time, PT-INR = PT-international normalized ratio, TgAb = thyroglobulin antibody, TPOAb = thyroid peroxidase antibody, TRAb = thyroid-stimulating hormone receptor antibody, TSAb = thyroid-stimulating antibody, TSH = thyroid-stimulating hormone, VCA = viral capsid antigen.